229 related articles for article (PubMed ID: 27603520)
1. PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo.
Aravantinou M; Frank I; Hallor M; Singer R; Tharinger H; Kenney J; Gettie A; Grasperge B; Blanchard J; Salazar A; Piatak M; Lifson JD; Robbiani M; Derby N
PLoS One; 2016; 11(9):e0161730. PubMed ID: 27603520
[TBL] [Abstract][Full Text] [Related]
2. Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy.
Miller E; Spadaccia M; Sabado R; Chertova E; Bess J; Trubey CM; Holman RM; Salazar A; Lifson J; Bhardwaj N
Vaccine; 2015 Jan; 33(2):388-95. PubMed ID: 25444812
[TBL] [Abstract][Full Text] [Related]
3. Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis.
Sionov E; Mayer-Barber KD; Chang YC; Kauffman KD; Eckhaus MA; Salazar AM; Barber DL; Kwon-Chung KJ
PLoS Pathog; 2015 Aug; 11(8):e1005040. PubMed ID: 26252005
[TBL] [Abstract][Full Text] [Related]
4. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon.
Akiyama H; Ramirez NP; Gibson G; Kline C; Watkins S; Ambrose Z; Gummuluru S
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794041
[TBL] [Abstract][Full Text] [Related]
5. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from Cryptococcus gattii Independently of T Cells.
Davis MJ; Moyer S; Hoke ES; Sionov E; Mayer-Barber KD; Barber DL; Cai H; Jenkins L; Walter PJ; Chang YC; Kwon-Chung KJ
mBio; 2019 Jun; 10(3):. PubMed ID: 31213551
[No Abstract] [Full Text] [Related]
7. Dendritic cells and HIV infection: activating dendritic cells to boost immunity.
Teleshova N; Kenney J; Robbiani M
Adv Dent Res; 2006 Apr; 19(1):36-41. PubMed ID: 16672547
[TBL] [Abstract][Full Text] [Related]
8. Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.
Zurawski G; Shen X; Zurawski S; Tomaras GD; Montefiori DC; Roederer M; Ferrari G; Lacabaratz C; Klucar P; Wang Z; Foulds KE; Kao SF; Yu X; Sato A; Yates NL; LaBranche C; Stanfield-Oakley S; Kibler K; Jacobs B; Salazar A; Self S; Fulp W; Gottardo R; Galmin L; Weiss D; Cristillo A; Pantaleo G; Levy Y
J Virol; 2017 May; 91(9):. PubMed ID: 28202751
[TBL] [Abstract][Full Text] [Related]
9. CpG-C immunostimulatory oligodeoxyribonucleotide activation of plasmacytoid dendritic cells in rhesus macaques to augment the activation of IFN-gamma-secreting simian immunodeficiency virus-specific T cells.
Teleshova N; Kenney J; Jones J; Marshall J; Van Nest G; Dufour J; Bohm R; Lifson JD; Gettie A; Pope M
J Immunol; 2004 Aug; 173(3):1647-57. PubMed ID: 15265893
[TBL] [Abstract][Full Text] [Related]
10. The interaction of immunodeficiency viruses with dendritic cells.
Steinman RM; Granelli-Piperno A; Pope M; Trumpfheller C; Ignatius R; Arrode G; Racz P; Tenner-Racz K
Curr Top Microbiol Immunol; 2003; 276():1-30. PubMed ID: 12797441
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Abortive HIV-1 RNAs Induce Potent Antiviral Immunity.
Stunnenberg M; Sprokholt JK; van Hamme JL; Kaptein TM; Zijlstra-Willems EM; Gringhuis SI; Geijtenbeek TBH
Front Immunol; 2020; 11():8. PubMed ID: 32038656
[TBL] [Abstract][Full Text] [Related]
12. Virus-encoded TLR ligands reveal divergent functional responses of mononuclear phagocytes in pathogenic simian immunodeficiency virus infection.
Wonderlich ER; Wijewardana V; Liu X; Barratt-Boyes SM
J Immunol; 2013 Mar; 190(5):2188-98. PubMed ID: 23338235
[TBL] [Abstract][Full Text] [Related]
13. Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice.
Sultan H; Wu J; Kumai T; Salazar AM; Celis E
Cancer Immunol Immunother; 2018 Jul; 67(7):1091-1103. PubMed ID: 29696308
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocycline.
Drewes JL; Szeto GL; Engle EL; Liao Z; Shearer GM; Zink MC; Graham DR
PLoS One; 2014; 9(4):e94375. PubMed ID: 24732038
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic, therapeutic and immune enhancement effect of liposome-encapsulated PolyICLC on highly pathogenic H5N1 influenza infection.
Li Y; Hu Y; Jin Y; Zhang G; Wong J; Sun LQ; Wang M
J Gene Med; 2011 Jan; 13(1):60-72. PubMed ID: 21259409
[TBL] [Abstract][Full Text] [Related]
16. Capture and transfer of simian immunodeficiency virus by macaque dendritic cells is enhanced by DC-SIGN.
Yu Kimata MT; Cella M; Biggins JE; Rorex C; White R; Hicks S; Wilson JM; Patel PG; Allan JS; Colonna M; Kimata JT
J Virol; 2002 Dec; 76(23):11827-36. PubMed ID: 12414925
[TBL] [Abstract][Full Text] [Related]
17. A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
Melssen MM; Petroni GR; Chianese-Bullock KA; Wages NA; Grosh WW; Varhegyi N; Smolkin ME; Smith KT; Galeassi NV; Deacon DH; Gaughan EM; Slingluff CL
J Immunother Cancer; 2019 Jun; 7(1):163. PubMed ID: 31248461
[TBL] [Abstract][Full Text] [Related]
18. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
J Virol; 2018 May; 92(9):. PubMed ID: 29467313
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.
Mehrotra S; Britten CD; Chin S; Garrett-Mayer E; Cloud CA; Li M; Scurti G; Salem ML; Nelson MH; Thomas MB; Paulos CM; Salazar AM; Nishimura MI; Rubinstein MP; Li Z; Cole DJ
J Hematol Oncol; 2017 Apr; 10(1):82. PubMed ID: 28388966
[TBL] [Abstract][Full Text] [Related]
20. Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that are associated with levels of plasma viremia and T cell activation in an exploratory study.
Dillon SM; Friedlander LJ; Rogers LM; Meditz AL; Folkvord JM; Connick E; McCarter MD; Wilson CC
J Virol; 2011 Jan; 85(1):397-409. PubMed ID: 20962079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
